RAPT Therapeutics stock surged over 63% after GSK agreed to buy the company for $58 per share in a $2.2 billion deal.

ImmunityBio shares jumped in premarket trading after the FDA outlined next steps for expanding ANKTIVA’s bladder cancer label ...

With risk assets retreating and commodities exploding higher, investors are hunting for durable growth stories trading below ...

M posted a Q4 earnings and revenue beat, delivering $1.83 adjusted EPS and $6.1 billion in sales, while forecasting growth in ...

D.R. Horton beat Wall Street estimates in Q1 fiscal 2026 as earnings rose to $2.03 per share and revenue came in at $6.9 ...

Fastenal posted Q4 EPS of $0.26, matching estimates, while revenue came in at $2.03B, slightly below forecasts. The company ...

ImmunityBio stock jumped after the company reported preliminary 2025 net product revenue of $113 million, up about 700% year ...

QXO stock declined over 6% in premarket trading after announcing a 31.6 million share offering priced at $23.80, below its ...

Wells Fargo topped Q4 profit expectations with $1.76 EPS, but revenue came in slightly below forecasts at $21.29 billion.

State Street shares slipped after the bank posted a Q4 earnings and revenue beat, but investors focused on restructuring ...

TSMC stock jumped nearly 6% in premarket trading after the company beat Q4 earnings estimates and raised its 2026 capex plan ...

JPMorgan reported Q4 adjusted EPS of $5.23, topping estimates, but shares fell over 2% as investors looked past strong ...